Clinical trial
Multicenter Prospective Non-interventional Study of the Efficacy and Safety of Longidaze®, Vaginal and Rectal Suppositories, 3000 IU, for the Treatment of Patients With External Genital Endometriosis
NCT04962620 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Prospective Non-interventional Study of the Efficacy and Safety of Longidaze®, Vaginal and Rectal Suppositories, 3000 IU, for the Treatment of Patients With External Genital Endometriosis
- Lead sponsor
- NPO Petrovax
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 26, 2019
- Completion date
- August 1, 2021
- Enrollment
- 149 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
external genital endometriosis